AMS-III-1086

N/A

Report date: 2025/01/26 17:12:51
NME

Base Information

Drug NameAMS-III-1086
Drug Alias Namelysophosphatidic acid-1 receptor antagonist (AM Sciences/Sungkyunkwan University/Samsung Medical Center)AMS-III-1086
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Active CompaniesAm Sciences IncSamsung Medical CenterSungkyunkwan University
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A